Monitoring of iron(III) removal from biological sources using a fluorescent siderophore.
We present here the physicochemical and biochemical properties of NBD-DFO, the 7-nitrobenz-2-oxa-1,3-diazole (NBD) derivative of the siderophore, desferrioxamine B (DFO) (Lytton et al., Mol. Pharmacol. 40, 584, 1991). Modification of DFO at its terminal amine renders it more lipophilic, imparts to it fluorescent properties, and is conservative of the high-affinity iron(III) binding capacity. NBD-DFO partitions readily from aqueous solution into n-octanol (Pcoeff = 5) and displays solvent-induced shifts in absorption and fluorescence spectra. The relative quantum yield of the probe's fluorescence increases over a 10-fold range with decreasing dielectric constant of the solvent. Fluorescence is quenched upon binding of iron(III) to the probe. We demonstrate here the application of NBD-DFO for the specific detection and monitoring of iron (III) in solutions and iron(III) mobilization from cells. Interactions between fluorescent siderophore and the ferriproteins ferritin and transferrin were monitored under physiological conditions. Iron removal from ferritin was evident by the demonstrable quenching of NBD-DFO fluorescence by scavenged iron(III). Quantitation of iron sequestered from cells by NBD-DFO or from other siderophore-iron(III) complexes was accomplished by dissociation of NBD-DFO-Fe complex by acidification and addition of excess ethylenediamin-etetraacetic acid. The sensitivity of the method and the iron specificity indicate its potential for monitoring chelatable iron under conditions of iron-mediated cell damage, iron overload, and diseases of iron imbalance such as malaria.
Lytton
S D
SD
Department of Biological Chemistry, Hebrew University, Jerusalem, Israel.
Mester
B
B
Libman
J
J
Shanzer
A
A
Cabantchik
Z I
ZI
D009327:4-Chloro-7-nitrobenzofurazan / Q000031:analogs & derivatives* / Q000737:chemistry; D006528:Carcinoma, Hepatocellular / Q000378:metabolism; D003676:Deferoxamine / Q000031:analogs & derivatives* / Q000737:chemistry; D005290:Ferric Compounds / Q000032:analysis*; D005453:Fluorescence; D006801:Humans; D008113:Liver Neoplasms / Q000378:metabolism; D008722:Methods; D014168:Transferrin / Q000032:analysis; D014407:Tumor Cells, Cultured
D005290:Ferric Compounds; D014168:Transferrin; C071323:7-nitrobenz-2-oxa-1,3-diazole desferrioxamine B; D009327:4-Chloro-7-nitrobenzofurazan; D003676:Deferoxamine